X-154039017-C-T

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001110792.2(MECP2):​c.63-6460G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.104 in 111,677 control chromosomes in the GnomAD database, including 669 homozygotes. There are 3,184 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.10 ( 669 hom., 3184 hem., cov: 22)

Consequence

MECP2
NM_001110792.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.816
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.205 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MECP2NM_001110792.2 linkc.63-6460G>A intron_variant ENST00000453960.7 NP_001104262.1 P51608-2A0A140VKC4Q59FJ6
MECP2NM_004992.4 linkc.27-6460G>A intron_variant ENST00000303391.11 NP_004983.1 P51608-1D3YJ43Q59FJ6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MECP2ENST00000453960.7 linkc.63-6460G>A intron_variant 1 NM_001110792.2 ENSP00000395535.2 P51608-2
MECP2ENST00000303391.11 linkc.27-6460G>A intron_variant 1 NM_004992.4 ENSP00000301948.6 P51608-1

Frequencies

GnomAD3 genomes
AF:
0.104
AC:
11570
AN:
111625
Hom.:
666
Cov.:
22
AF XY:
0.0937
AC XY:
3173
AN XY:
33859
show subpopulations
Gnomad AFR
AF:
0.210
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0792
Gnomad ASJ
AF:
0.0412
Gnomad EAS
AF:
0.0120
Gnomad SAS
AF:
0.0376
Gnomad FIN
AF:
0.0546
Gnomad MID
AF:
0.0417
Gnomad NFE
AF:
0.0679
Gnomad OTH
AF:
0.0857
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.104
AC:
11591
AN:
111677
Hom.:
669
Cov.:
22
AF XY:
0.0939
AC XY:
3184
AN XY:
33921
show subpopulations
Gnomad4 AFR
AF:
0.210
Gnomad4 AMR
AF:
0.0790
Gnomad4 ASJ
AF:
0.0412
Gnomad4 EAS
AF:
0.0118
Gnomad4 SAS
AF:
0.0366
Gnomad4 FIN
AF:
0.0546
Gnomad4 NFE
AF:
0.0679
Gnomad4 OTH
AF:
0.0945
Alfa
AF:
0.0517
Hom.:
350
Bravo
AF:
0.110

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
0.27
DANN
Benign
0.60

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3027935; hg19: chrX-153304468; API